Current status of tissue kallikrein inhibitors: Importance in cancer

Kanti Bhoola, Neil Misso, A. Naran, Philip Thompson

    Research output: Contribution to journalArticlepeer-review

    16 Citations (Scopus)


    The past decade has seen an increase in the understanding of the structure and function of protease inhibitors. The molecular basis of the interaction between a variety of biological substrates or synthetic inhibitors and serine proteases of the kallikrein family has provided insights into inhibitor protein-protease reactive site interactions, which have proved of value in the design of new kallikrein inhibitors. This review focuses on the current understanding of the functional status of kallikrein inhibitors, which include a variety of molecules derived from plant, reptile and mammalian sources, as well as synthetic agents.
    Original languageEnglish
    Pages (from-to)462-468
    JournalCurrent Opinion in Investigational Drugs
    Issue number6
    Publication statusPublished - 2007


    Dive into the research topics of 'Current status of tissue kallikrein inhibitors: Importance in cancer'. Together they form a unique fingerprint.

    Cite this